Herbal Medicine for Chronic Lung Conditions (NRICM102)
Part of Lungs & breathing clinical trials.
This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a long-term lower airway condition (like asthma, COPD, or lung fibrosis) diagnosed by a lung doctor
- Have had a chronic cough or cough with phlegm for at least 3 months while on your regular breathing medication
- Be willing to see a Traditional Chinese doctor to check if the study treatment (NRICM102) is right for you
- Not be pregnant or breastfeeding, and not have had a serious lung crisis needing ICU care in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding NRICM102, a traditional Chinese medicine, to standard antibiotic treatment helps hospitalized patients with community-acquired pneumonia (a lung infection acquired outside a hospital) recover better. You would receive the herbal medicine by mouth along with your regular antibiotics.
This trial tests a traditional Chinese herbal compound formula for people with COPD. It aims to see if the herbal treatment can help improve lung health when used on top of standard inhaler therapy.
This trial tests a new medicine, HW091077, for people who have had a chronic cough for at least a year that hasn't gotten better with treatment or has no clear cause. It aims to see if the drug can help reduce coughing.
This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
Hear when a new Chronic Lower Respiratory Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.